| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
59,769 |
53,412 |
$2.05M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
26,029 |
23,919 |
$1.49M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
11,020 |
10,622 |
$722K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
28,543 |
22,021 |
$711K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
23,201 |
21,015 |
$658K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
9,657 |
9,221 |
$582K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
6,548 |
5,784 |
$555K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
7,537 |
7,313 |
$488K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
8,771 |
8,366 |
$388K |
| 90461 |
|
12,013 |
11,255 |
$315K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,896 |
2,793 |
$208K |
| 96160 |
|
41,459 |
31,764 |
$129K |
| H0049 |
Alcohol and/or drug screening |
3,337 |
3,196 |
$67K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,283 |
4,093 |
$61K |
| 95117 |
|
4,697 |
1,719 |
$57K |
| 96127 |
|
15,405 |
14,245 |
$55K |
| 99429 |
|
629 |
621 |
$45K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
5,220 |
4,814 |
$40K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,141 |
1,081 |
$33K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,140 |
1,080 |
$33K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,227 |
2,178 |
$29K |
| 99408 |
|
742 |
731 |
$27K |
| 99188 |
|
1,718 |
1,659 |
$24K |
| 96161 |
|
7,085 |
6,667 |
$19K |
| 90686 |
|
9,802 |
9,449 |
$18K |
| 92551 |
|
1,839 |
1,769 |
$18K |
| 92583 |
|
796 |
771 |
$17K |
| 80061 |
Lipid panel |
1,316 |
1,260 |
$16K |
| 90670 |
|
5,574 |
5,369 |
$15K |
| 36416 |
|
10,488 |
9,800 |
$13K |
| 99051 |
|
7,485 |
7,175 |
$10K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
674 |
322 |
$10K |
| 94760 |
|
5,632 |
5,020 |
$9K |
| 83655 |
|
766 |
727 |
$9K |
| 0072A |
|
245 |
232 |
$8K |
| 90723 |
|
3,646 |
3,529 |
$7K |
| 0002A |
|
217 |
212 |
$7K |
| 0001A |
|
201 |
198 |
$6K |
| 82948 |
|
1,295 |
1,237 |
$6K |
| 99173 |
|
129 |
126 |
$5K |
| 90647 |
|
3,327 |
3,198 |
$5K |
| 80305 |
|
466 |
439 |
$5K |
| 0071A |
|
167 |
161 |
$5K |
| 90480 |
|
122 |
121 |
$4K |
| 99174 |
|
202 |
197 |
$4K |
| 90633 |
|
1,147 |
1,102 |
$3K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
64 |
63 |
$3K |
| 81003 |
|
1,454 |
1,321 |
$3K |
| 90681 |
|
832 |
797 |
$2K |
| 90651 |
|
304 |
295 |
$2K |
| 90685 |
|
266 |
258 |
$2K |
| 99462 |
|
78 |
73 |
$2K |
| 99460 |
|
40 |
40 |
$2K |
| 97803 |
|
168 |
163 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
157 |
124 |
$2K |
| D1206 |
Topical application of fluoride varnish |
100 |
97 |
$1K |
| 90677 |
|
505 |
499 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
57 |
53 |
$910.92 |
| 0004A |
|
27 |
27 |
$880.00 |
| 0082A |
|
45 |
38 |
$867.20 |
| 90656 |
|
526 |
522 |
$843.80 |
| 0074A |
|
29 |
27 |
$830.00 |
| 98960 |
|
27 |
27 |
$539.98 |
| 97802 |
|
66 |
63 |
$486.67 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
31 |
27 |
$401.80 |
| 82947 |
|
113 |
111 |
$347.66 |
| 69210 |
|
15 |
13 |
$342.06 |
| 99000 |
|
3,229 |
3,065 |
$338.92 |
| 0081A |
|
18 |
14 |
$280.00 |
| 82436 |
|
42 |
39 |
$236.67 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
18 |
12 |
$203.70 |
| 90734 |
|
127 |
126 |
$202.40 |
| 94761 |
|
52 |
49 |
$167.58 |
| 91321 |
|
16 |
15 |
$145.92 |
| 90707 |
|
31 |
30 |
$128.80 |
| 90715 |
|
12 |
12 |
$115.88 |
| 91319 |
|
19 |
18 |
$87.78 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
82 |
81 |
$63.18 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
133 |
125 |
$24.65 |
| 36415 |
Collection of venous blood by venipuncture |
13 |
13 |
$22.90 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
147 |
116 |
$14.93 |
| 3008F |
|
8,146 |
7,950 |
$0.00 |
| 91307 |
|
538 |
468 |
$0.00 |
| 90716 |
|
61 |
55 |
$0.00 |
| 90696 |
|
29 |
25 |
$0.00 |
| 91318 |
|
16 |
14 |
$0.00 |
| 90620 |
|
13 |
13 |
$0.00 |
| 2014F |
|
3,137 |
3,070 |
$0.00 |
| 90710 |
|
29 |
28 |
$0.00 |
| 91300 |
|
557 |
510 |
$0.00 |
| 91308 |
|
164 |
136 |
$0.00 |
| 90700 |
|
17 |
17 |
$0.00 |